MAP2K5 and breast carcinoma: In breast cancer models, the MEK5–ERK5 axis was identified as a critical mediator; blocking this pathway counteracted TGFβ-induced EMT and reduced the motility and invasiveness of breast cancer cells (Pavan et al., 2018).